1. Bioinformatics for cancer immunotherapy target discovery

   • Lars Rønn Olsen
   • Benito Campos
   • Mads Hald Andersen

   Review 26 October 2014 Pages: 1235 - 1249

   

2. A multiplex method for the detection of serum antibodies against in silico-predicted tumor antigens

   • Miriam Reuschenbach
   • Jonathan Dörre
   • Magnus von Knebel Doeberitz

   Original Article 21 August 2014 Pages: 1251 - 1259

   

3. Tuftsin-based, EGFR-targeting fusion protein and its enediyne-energized analog show high antitumor efficacy associated with CD47 down-regulation

   • Wen-Juan Liu
   • Xiu-Jun Liu
   • Yong-Su Zhen

   Original Article 28 August 2014 Pages: 1261 - 1272

   

4. Phenotyping of peripheral blood mononuclear cells of patients with advanced heavily pre-treated adenocarcinoma of the stomach and gastro-esophageal junction

   • Marie-Cristine Kuehnle
   • Sebastian Attig
   • Özlem Türeci

   Original Article 28 August 2014 Pages: 1273 - 1284

   

5. Activation of CD1d-restricted natural killer T cells can inhibit cancer cell proliferation during chemotherapy by promoting the immune responses in murine mesothelioma

   • Licun Wu
   • Zhihong Yun
   • Marc de Perrot

   Original Article 03 September 2014 Pages: 1285 - 1296

   

6. Interactions between neutrophils and non-small cell lung cancer cells: enhancement of tumor proliferation and inflammatory mediator synthesis

   • Katja Hattar
   • Katharina Franz
   • Ulrich Grandel

   Original Article Open access 04 September 2014 Pages: 1297 - 1306

   

7. Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis

   • Jo A. Tucker
   • Caroline Jochems
   • Kwong-Yok Tsang

   Original Article 04 September 2014 Pages: 1307 - 1317

   

8. High placenta-specific 1/low prostate-specific antigen expression pattern in high-grade prostate adenocarcinoma

   • Roya Ghods
   • Mohammad-Hossein Ghahremani
   • Amir-Hassan Zarnani

   Original Article 04 September 2014 Pages: 1319 - 1327

   

9. Sequential immune monitoring in patients with melanoma and renal cell carcinoma treated with high-dose interleukin-2: immune patterns and correlation with outcome

   • David M. Foureau
   • Asim Amin
   • Jonathan C. Salo

   Original Article 10 September 2014 Pages: 1329 - 1340

   

10. Successful treatment with Ipilimumab and Interleukin-2 in two patients with metastatic melanoma and systemic autoimmune disease

    • Magnus Pedersen
    • Rikke Andersen
    • Inge Marie Svane

    Original Article 17 September 2014 Pages: 1341 - 1346

    

11. Inconsistencies and questionable reliability of the publication “Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophages-activating, GcMAF” by Yamamoto et al

    • Ana Ugarte
    • Gauthier Bouche
    • Lydie Meheus

    Letter to the Editors Open access 24 July 2014 Pages: 1347 - 1348

12. Retraction Note to: Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF

    • Nobuto Yamamoto
    • Hirofumi Suyama
    • Yoshihiko Koga

    Retraction Note 09 October 2014 Pages: 1349 - 1349